Can chemotherapy increase the risk of heart problems?
Answer From Joerg Herrmann, M.D.
Yes, some conventional chemotherapy drugs used to treat cancer can increase your risk of heart problems. Heart problems can also happen with newer targeted therapy drugs and with radiation therapy.
Examples of heart-related problems that can happen with cancer treatments include:
- Weakening of the heart muscle (cardiomyopathy)
- Heart rhythm problems (arrhythmia)
- Heart attack
- High blood pressure
- Blood clots
Whether you're at risk for heart problems during and after cancer treatment depends on how healthy your heart is and the specific drugs you'll be receiving. Some drugs may carry a higher risk of heart problems in people who already have heart problems. Sometimes the risk is higher if you take a higher dose of the drug.
If your doctor is considering a cancer treatment that may affect your heart, you may undergo heart function testing before starting treatment. If you have a preexisting heart condition, such as cardiomyopathy, your doctor might suggest a different type of chemotherapy.
You may need periodic heart monitoring during treatment, depending on the type of chemotherapy you receive. Monitoring might continue after treatment, too.
Cancer doctors (oncologists) and heart doctors (cardiologists) sometimes work together to provide care for people who have a risk of heart problems during and after cancer treatment. This area of medicine is sometimes referred to as cardio-oncology.
Joerg Herrmann, M.D.
Oct. 21, 2020
From Mayo Clinic to your inbox
Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health.
ErrorEmail field is required
ErrorInclude a valid email address
To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
Thank you for subscribing
Our Housecall e-newsletter will keep you up-to-date on the latest health information.
Sorry something went wrong with your subscription
Please, try again in a couple of minutes
See more Expert Answers
- Babiker HM, et al. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system. Critical Reviews in Oncology/Hematology. 2018;126:186.
- Armenian SH, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2017;35;893.
- Herrmann J, et al. Evaluation and management of patients with heart disease and cancer: Cardio-oncology. Mayo Clinic Proceedings. 2014;89:1287.
- Herrmann J (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 29, 2018.